Auilix Biopharma

Auilix Biopharma, Inc. is a domestic shareholding company registered in the United States in 2000, with SOS/FTB suspending operations. The company is a biotechnology firm focused on the development of regulatory genomics and cell-based assays. Its technology can interrogate discrete cellular signaling pathways and uncover direct protein targets within compounds. It concentrates on drug discovery in the fields of cancer, heart disease, inflammation and autoimmune diseases, obesity, diabetes, and neurodegenerative diseases. The company utilizes the Auilix drug exploration engine to discover regulatory modules within disease pathways.